Literature DB >> 34254584

Role of BRCA2 DNA-binding and C-terminal domain on its mobility and conformation in DNA repair.

Maarten W Paul1, Arshdeep Sidhu2, Yongxin Liang1, Sarah E van Rossum-Fikkert2, Hanny Odijk1, Alex N Zelensky1, Roland Kanaar1, Claire Wyman2.   

Abstract

BRCA2 is an essential protein in genome maintenance, homologous recombination and replication fork protection. Its function includes multiple interaction partners and requires timely localization to relevant sites in the nucleus. We investigated the importance of the highly conserved DNA binding domain (DBD) and C-terminal domain (CTD) of BRCA2. We generated BRCA2 variants missing one or both domains in mouse ES cells and defined their contribution in HR function and dynamic localization in the nucleus, by single particle tracking of BRCA2 mobility. Changes in molecular architecture of BRCA2 induced by binding partners of purified BRCA2 was determined by scanning force microscopy. BRCA2 mobility and DNA damage-induced increase in the immobile fraction was largely unaffected by C-terminal deletions. The purified proteins missing CTD and/or DBD were defective in architectural changes correlating with reduced homologous recombination function in cells. These results emphasize BRCA2 activity at sites of damage beyond promoting RAD51 delivery.
© 2021, Paul et al.

Entities:  

Keywords:  biochemistry; cell biology; chemical biology; human; mouse

Year:  2021        PMID: 34254584     DOI: 10.7554/eLife.67926

Source DB:  PubMed          Journal:  Elife        ISSN: 2050-084X            Impact factor:   8.140


  1 in total

1.  Dipeptidyl peptidase 9 triggers BRCA2 degradation and promotes DNA damage repair.

Authors:  Oguz Bolgi; Maria Silva-Garcia; Breyan Ross; Esther Pilla; Vijayalakshmi Kari; Markus Killisch; Melanie Spitzner; Nadine Stark; Christof Lenz; Konstantin Weiss; Laura Donzelli; Mark D Gorrell; Marian Grade; Jan Riemer; Henning Urlaub; Matthias Dobbelstein; Robert Huber; Ruth Geiss-Friedlander
Journal:  EMBO Rep       Date:  2022-08-01       Impact factor: 9.071

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.